Baker McKenzie advised Hudson Bay Capital Management on its  convertible bond investment of up to 36 million euros in Visiomed Group.

Visiomed Group is a company listed on Euronext Growth Paris which specialises in the development and marketing of innovative connected medical devices.  

The financing was structured as a private issuance of warrants for bonds convertible into shares with equity warrants attached (BEOCABSA).

The purpose of the transaction is to enable Visiomed Group to continue its development on the connected healthcare market.  

The Baker McKenzie team was led by François-Xavier Naime, partner, assisted by Giuliano Lastrucci and Raphaël Sendowski, associates. 
Explore Our Newsroom
See All News